{
}
Ambev (NYSE:ABEV) has had its price target raised by Barclays from $2.00 to $2.50, maintaining an "equal weight" rating. Despite this, analysts generally hold a "Hold" consensus rating, with one buy, four holds, and one sell rating. The company reported earnings of $0.04 per share, matching expectations, with a revenue of $3.92 billion for the quarter.
Barclays has raised its price target for Ambev (ABEV) from $2.00 to $2.50, reflecting a 25% increase and an optimistic outlook, while maintaining an "Equal-Weight" rating. Analysts forecast an average target price of $2.75, indicating a potential upside of 10.39% from the current price of $2.49, with a consensus recommendation of "Hold." GuruFocus estimates a fair value of $2.85, suggesting a 14.46% upside.
Ambev (ABEV) has received an increased price target of $2.50 from Barclays, maintaining an Equal Weight rating. The company reported a high single-digit revenue growth and a 0.7% volume increase in Q1, achieving record levels, while EBITDA grew by double digits with margin expansion. An intermediary dividend of BRL 2 billion was announced, reflecting Ambev's commitment to shareholder returns.
Ambev (NYSE:ABEV) has been downgraded by UBS Group from a "buy" to a "neutral" rating, reflecting a broader trend among analysts, with one sell rating, four hold ratings, and one buy rating. The stock currently has an average rating of "Hold" and a consensus target price of $2.45. Recently, Ambev reported earnings of $0.05 per share, missing estimates, and had a revenue of $4.63 billion for the quarter.
UBS has downgraded Ambev (ABEV) from Buy to Neutral, setting a new price target of R$16, following a 20% rise in shares this year. Analysts suggest the stock's risk-reward balance is now even, with an average one-year price target of $2.89, indicating a potential upside of 20.39% from the current price of $2.40. The consensus recommendation from brokerage firms is a "Hold" status, with an estimated fair value of $2.47 according to GuruFocus.
Ambev SA
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Ambev stock price target raised amid mixed analyst ratings and performance
15:51 14.05.2025
Barclays raises Ambev price target to 2.50 amid positive outlook
17:00 12.05.2025
Ambev reports strong Q1 results and raises price target to 2.50
12:17 12.05.2025
Ambev downgraded to neutral as analysts reassess stock performance and ratings
13:38 24.04.2025
ubs downgrades ambev to neutral amid balanced risk reward assessment
22:32 21.04.2025
Trending
Subcategory
Countries:
Companies:
Currencies:
People: